Thomas O’Brien

668 total citations
32 papers, 384 citations indexed

About

Thomas O’Brien is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Emergency Medicine. According to data from OpenAlex, Thomas O’Brien has authored 32 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 6 papers in Emergency Medicine. Recurrent topics in Thomas O’Brien's work include Hedgehog Signaling Pathway Studies (5 papers), Cardiac Arrest and Resuscitation (5 papers) and Cardiac Structural Anomalies and Repair (5 papers). Thomas O’Brien is often cited by papers focused on Hedgehog Signaling Pathway Studies (5 papers), Cardiac Arrest and Resuscitation (5 papers) and Cardiac Structural Anomalies and Repair (5 papers). Thomas O’Brien collaborates with scholars based in United States, Canada and Germany. Thomas O’Brien's co-authors include Mounira Habli, John R. Barton, Saeb F. Khoury, Baha M. Sibai, Eugene S. Chung, Santosh Menon, Cheryl Bartone, Geoffrey Chan, Michael Heuser and Jörge E. Cortes and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Thomas O’Brien

27 papers receiving 370 citations

Peers

Countries citing papers authored by Thomas O’Brien

Since Specialization

Citations

This map shows the geographic impact of Thomas O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas O’Brien more than expected).

Fields of papers citing papers by Thomas O’Brien

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas O’Brien. The network helps show where Thomas O’Brien may publish in the future.

Co-authorship network of co-authors of Thomas O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas O’Brien. A scholar is included among the top collaborators of Thomas O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas O’Brien. Thomas O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maternal exposure to polyethylene micro- and nanoplastics impairs umbilical blood flow but not fetal growth in pregnant mice 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), Thomas O’Brien, (unknown), (unknown), Christopher K. Macgowan, Ahmet Baschat, John‏ Kingdom, André J. Simpson, Myrna J. Simpson, John G. Sled, Karl J. Jobst, Lindsay S. Cahill	21
2	Differential impact of perfluorooctanoic acid and fluorotelomer ethoxylates on placental metabolism in mice 2024 ·Chemosphere ·(unknown), (unknown), (unknown), Thomas O’Brien, (unknown), (unknown), C. Schneider, Karl J. Jobst, Lindsay S. Cahill	3
3	Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial 2023 ·Leukemia ·Mikkael A. Sekeres, Pau Montesinos, Jan Novák, Jianxiang Wang, Deepa Jeyakumar, Benjamin Tomlinson, Jiřı́ Mayer, Erin Jou, Tadeusz Robak, David Taussig, Hervé Dombret, Akil Merchant, M. Naveed Shaik, Thomas O’Brien, Whijae Roh, Xueli Liu, (unknown), (unknown), Geoffrey Chan, Jörge E. Cortes	15
4	Genomic analysis to identify determinants of inherent response and resistance to elranatamab in MagnetisMM-3 cohort A. 2023 ·Journal of Clinical Oncology ·Nizar J. Bahlis, Hang Quach, Katja Weisel, Andrea Viqueira, Shen‐Wu Wang, Phineas T. Hamilton, Tao Xie, Thomas O’Brien, Paula Rodríguez‐Otero	2
5	RESOURCE UTILIZATION IN HEART FAILURE PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES 2023 ·Journal of the American College of Cardiology ·(unknown), (unknown), (unknown), Gregory F. Egnaczyk, Ankit Bhatia, (unknown), Vien T. Truong, Thomas O’Brien, Eugene S. Chung	1
6	A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromes 2022 ·Annals of Hematology ·Mikkael A. Sekeres, Michael Schuster, Magalie Joris, Jürgen Krauter, Johan Maertens, Dimitri Breems, Emmanuel Gyan, Tibor Kovacsovics, Amit Verma, Paresh Vyas, Eunice S. Wang, Keith A. Ching, Thomas O’Brien, Corrado Gallo Stampino, Weidong Wendy, Arthur J. Kudla, Geoffrey Chan, Amer M. Zeidan	11
7	Left Ventricular Assist Device in Patients With Alcohol Abuse or Illicit Drug Use 2022 ·The American Journal of Cardiology ·Vien T. Truong, Gregory F. Egnaczyk, Thomas O’Brien, (unknown), (unknown), Satya Shreenivas, (unknown), Eugene S. Chung	2
8	Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial 2021 ·Annals of Hematology ·Michael Heuser, B. Douglas Smith, Walter Fiedler, Mikkael A. Sekeres, Pau Montesinos, Brian Leber, Akil Merchant, Cristina Papayannidis, Josè Antonio Pérez-Simón, (unknown), Thomas O’Brien, Weidong Wendy, Mirjana Zeremski, Ashleigh O’Connell, Geoffrey Chan, Jörge E. Cortes	36
9	Implementing an Algorithm for Mechanical Support in Cardiogenic Shock Improves Survival 2021 ·The Journal of Heart and Lung Transplantation ·(unknown), Kari Gorder, (unknown), Thomas O’Brien, (unknown), (unknown), (unknown), (unknown), Satya Shreenivas, (unknown), (unknown), Gregory F. Egnaczyk, (unknown)	2
10	Veno-Venous Extracorporeal Membrane Oxygenation - Rapid Recovery for Post-Surgical Negative Pressure Pulmonary Edema 2021 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), Mike Scott, Thomas O’Brien	1
11	Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy 2020 ·Journal of Hematology & Oncology ·Jörge E. Cortes, Florian H. Heidel, Walter Fiedler, Benjamin D. Smith, Tadeusz Robak, Pau Montesinos, Anna Candoni, Brian Leber, Mikkael A. Sekeres, Daniel A. Pollyea, (unknown), Weidong Wendy, Thomas O’Brien, Ashleigh O’Connell, Geoffrey Chan, Michael Heuser	29
12	The Past, Present and Future of Cardiac Resynchronization Therapy 2019 ·Korean Circulation Journal ·Thomas O’Brien, Myung Soo Park, Jong‐Chan Youn, Eugene Chung	10
13	Management and outcomes following pancreaticoduodenectomy for ampullary adenocarcinoma 2017 ·The American Journal of Surgery ·(unknown), John P. Sharpe, Thomas O’Brien, Kurt T. Patton, David C. Portnoy, Noam A. VanderWalde, Jeremiah L. Deneve, David Shibata, Stephen W. Behrman, Paxton V. Dickson	17
14	Well‐Differentiated, Non‐Functional, Non‐Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management 2016 ·World Journal of Surgery ·(unknown), Jason W. Denbo, John P. Sharpe, Michael G. Martin, Thomas O’Brien, Rajib Gupta, (unknown), Stephen W. Behrman, Paxton V. Dickson	11
15	Indications for Cardiac Resynchronization Therapy 2014 ·Cardiology Clinics ·Thomas O’Brien, Edward J. Schloss, Eugene Chung	2
16	Out of control little-used clinical assets are draining healthcare budgets. 2012 ·PubMed ·Ruslan Horblyuk, (unknown), (unknown), Christopher W. Mullins, Thomas O’Brien, Ankita Roy	3
17	Target Weight Guided Treatment of Acute Heart Failure Using Ultrafiltration or Usual Care: Results of a Randomized Pilot Study 2010 ·Journal of Cardiac Failure ·Cheryl Bartone, Santosh Menon, Dean J. Kereiakes, Thomas O’Brien, Wojciech Mazur, (unknown), Eugene S. Chung	3
18	Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome 2008 ·American Journal of Obstetrics and Gynecology ·Mounira Habli, Thomas O’Brien, (unknown), Saeb F. Khoury, John R. Barton, Baha M. Sibai	87
19	Unusual soft tissue tumor. 1989 ·BMJ ·(unknown), (unknown), Thomas O’Brien	0
20	Pseudocysts of the pancreas causing massive gastrointestinal haemorrhage 1979 ·Irish Journal of Medical Science (1971 -) ·Thomas O’Brien, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact